发明公开
EP1207906A1 TREATMENT OF PATIENTS HAVING NON-HODGKINS LYMPHOMA WITH BONE MARROW INVOLVEMENT WITH ANTI-CD20 ANTIBODIES
审中-公开
非霍奇金淋巴瘤的患者的骨髓治疗与抗CD20抗体的参与
- 专利标题： TREATMENT OF PATIENTS HAVING NON-HODGKINS LYMPHOMA WITH BONE MARROW INVOLVEMENT WITH ANTI-CD20 ANTIBODIES
- 专利标题（中）： 非霍奇金淋巴瘤的患者的骨髓治疗与抗CD20抗体的参与
-
申请号： EP00965561.4申请日： 2000-07-25
-
公开(公告)号： EP1207906A1公开(公告)日： 2002-05-29
- 发明人: RASTETTER, William, H.
- 申请人： IDEC PHARMACEUTICALS CORPORATION
- 申请人地址： 11011 Torreyana Road San Diego, CA 92121-1104 US
- 专利权人： IDEC PHARMACEUTICALS CORPORATION
- 当前专利权人： IDEC PHARMACEUTICALS CORPORATION
- 当前专利权人地址： 11011 Torreyana Road San Diego, CA 92121-1104 US
- 代理机构： Daniels, Jeffrey Nicholas
- 优先权： US148287P 19990811
- 国际公布： WO0110462 20010215
- 主分类号： A61K39/395
- IPC分类号： A61K39/395
摘要：
This invention relates to methods of reducing bone marrow involvement in B cell lymphoma patients prior to radioimmunotherapy by administering monoclonal antibodies which target cancerous B cells.
信息查询
